Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Nov 19, 2019 · 10-Q · 50 days after period end · 0001493152-19-018042
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$991.13K | -$214.03K | -$3.54M | -$3.24M |
| EPS Diluted | -$0.01 | -$0.04 | -$0.13 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 19, 2019 · 50 d after period end
